Autosomal dominant tubulointerstitial kidney disease: A review
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2022-09 · 190 (3) · 309-324
DOI: 10.1002/ajmg.c.32008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 17.10.2022. Verfasst von Martina Živná und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, C…. Hauptthemen laut MEDLINE: Genetic Testing, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Ministerstvo Zdravotnictví Ceské Republiky, Univerzita Karlova v Praze.
Abstract (Originalsprache)
The clinical characteristics of autosomal dominant tubulointerstitial kidney disease (ADTKD) include bland urinary sediment, slowly progressive chronic kidney disease (CKD) with many patients reaching end stage renal disease (ESRD) between age 20 and 70 years, and autosomal dominant inheritance. Due to advances in genetic diagnosis, ADTKD is becoming increasingly recognized as a cause of CKD. Pathogenic variants in UMOD , MUC1 , and REN are the most common causes of ADTKD. ADTKD‐ UMOD is also associated with hyperuricemia and gout. ADTKD‐ REN often presents in childhood with mild hypotension, CKD, hyperkalemia, acidosis, and anemia. ADTKD‐ MUC1 patients present only with CKD. This review describes the pathophysiology, genetics, clinical manifestation, and diagnosis for ADTKD, with an emphasis on genetic testing and genetic counseling suggestions for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit of Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Wake Forest University School of Medicine, Section on Nephrology, Winston-Salem, North Carolina, USA.
ORCID-Profile: Anthony J Bleyer
Förderung
- NIDDK NIH HHS
- Ministerstvo Zdravotnictví Ceské Republiky
- Univerzita Karlova v Praze
Zitieren
APA
Živná, M., Kidd, K. O., Barešová, V., Hůlková, H., Kmoch, S., & Bleyer, A. J. (2022). Autosomal dominant tubulointerstitial kidney disease: A review. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 190(3), 309-324. https://doi.org/10.1002/ajmg.c.32008
Vancouver
Živná M, Kidd KO, Barešová V, Hůlková H, Kmoch S, Bleyer AJ. Autosomal dominant tubulointerstitial kidney disease: A review. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2022;190(3):309-324. doi:10.1002/ajmg.c.32008
BibTeX
@article{ivn2022,
author = {Živná, Martina and Kidd, Kendrah O and Barešová, Veronika and Hůlková, Helena and Kmoch, Stanislav and Bleyer, Anthony J},
title = {Autosomal dominant tubulointerstitial kidney disease: A review},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2022},
volume = {190},
number = {3},
pages = {309--324},
doi = {10.1002/ajmg.c.32008}
}
EUVIMED